These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


719 related items for PubMed ID: 19808361

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA, Wendt C, Saborowski F.
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [Abstract] [Full Text] [Related]

  • 3. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J, Fraccarollo D.
    Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
    [Abstract] [Full Text] [Related]

  • 4. Use of diuretics in heart failure and cirrhosis.
    Schrier RW.
    Semin Nephrol; 2011 Nov; 31(6):503-12. PubMed ID: 22099507
    [Abstract] [Full Text] [Related]

  • 5. Aldosterone antagonists in congestive heart failure.
    Soberman J, Chafin CC, Weber KT.
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1024-8. PubMed ID: 12186262
    [Abstract] [Full Text] [Related]

  • 6. [Diuretic therapy in congestive heart failure--new views on spironolactone therapy].
    Haller C.
    Ther Umsch; 2000 Jun; 57(6):374-9. PubMed ID: 10894022
    [Abstract] [Full Text] [Related]

  • 7. Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure.
    Butler J, Hernandez AF, Anstrom KJ, Kalogeropoulos A, Redfield MM, Konstam MA, Tang WH, Felker GM, Shah MR, Braunwald E.
    JACC Heart Fail; 2016 Sep; 4(9):726-35. PubMed ID: 27522631
    [Abstract] [Full Text] [Related]

  • 8. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, Di Pasquale P.
    Am J Cardiol; 2009 Jan 01; 103(1):93-102. PubMed ID: 19101237
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy.
    Tan LB, Schlosshan D, Barker D.
    Int J Cardiol; 2004 Sep 01; 96(3):321-33. PubMed ID: 15310530
    [Abstract] [Full Text] [Related]

  • 11. Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome.
    Schrier RW, Masoumi A, Elhassan E.
    Clin J Am Soc Nephrol; 2010 Jun 01; 5(6):1132-40. PubMed ID: 20448074
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Factors predicting hyperkalemia in patients with cirrhosis receiving spironolactone.
    Abbas Z, Mumtaz K, Salam A, Jafri W.
    J Coll Physicians Surg Pak; 2003 Jul 01; 13(7):382-4. PubMed ID: 12887837
    [Abstract] [Full Text] [Related]

  • 16. [The significance of aldosterone in chronic heart failure: the RALES study].
    Simko F, Bada V, Simková M, Simko J, Kovács L, Hulín I.
    Vnitr Lek; 2002 Aug 01; 48(8):767-72. PubMed ID: 12425209
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
    Schrier RW.
    Am J Med; 2006 Jul 01; 119(7 Suppl 1):S47-53. PubMed ID: 16843085
    [Abstract] [Full Text] [Related]

  • 19. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP, Aaronson KD, Koelling TM.
    Am Heart J; 2004 Dec 01; 148(6):971-8. PubMed ID: 15632880
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.